Dario Sorrentino
#129,591
Most Influential Person Now
Italian medical researcher
Dario Sorrentino's AcademicInfluence.com Rankings
Dario Sorrentinolaw Degrees
Law
#3430
World Rank
#4339
Historical Rank
Common Law
#249
World Rank
#271
Historical Rank
Download Badge
Law
Dario Sorrentino's Degrees
- Bachelors Medicine University of Milan
Why Is Dario Sorrentino Influential?
(Suggest an Edit or Addition)According to Wikipedia, Dario Rosario Sorrentino was an Italian medical researcher. In 2021, Sorrentino was Professor of Medicine and Director of the Inflammatory Bowel Diseases Center at Virginia Tech Carilion School of Medicine and had held a Faculty position at the University of Udine Medical School in Italy.
Dario Sorrentino's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection. (2016) (212)
- Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. (2010) (150)
- Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. (2007) (123)
- "Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. (2007) (110)
- Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. (1997) (110)
- Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: Viral detection in gastric low‐grade lymphoma associated with autoimmune disease and in chronic gastritis (2000) (92)
- MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum. (2008) (82)
- Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn’s Disease: Partial Benefit by Infliximab—A Pilot Study (2012) (72)
- Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: An expert consensus report (2012) (71)
- Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort (2017) (69)
- Prevention of postoperative recurrence of Crohn's disease by infliximab. (2006) (59)
- Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn’s disease (2006) (57)
- B cell clonality in gastric lymphoid tissues of patients with Sjögren's syndrome. (1996) (54)
- Widespread clonal B-cell disorder in Sjögren's syndrome predisposing to Helicobacter pylori-related gastric lymphoma. (1996) (48)
- Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus. (2012) (47)
- Superior Mesenteric Artery Syndrome: Clinical, Endoscopic, and Radiological Findings (2018) (45)
- Internet use among inflammatory bowel disease patients: an Italian multicenter survey (2009) (43)
- State-of-the-art medical prevention of postoperative recurrence of Crohn's disease (2013) (41)
- B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma. (1996) (40)
- Helicobacter pylori Associated Antigastric Autoantibodies: Role in Sjögren's Syndrome Gastritis (2004) (34)
- Role of Biologics and Other Therapies in Stricturing Crohn’s Disease: What Have We Learnt So Far? (2008) (33)
- Diagnosis and assessment of Crohn’s disease: the present and the future (2010) (31)
- Scientific Publications in Gastroenterology and Hepatology in Western Europe, USA and Japan in the Years 1992–1996: A Global Survey (2000) (29)
- Stopping Anti-TNF Agents in Patients with Crohn's Disease in Remission: Is It a Feasible Long-term Strategy? (2014) (29)
- An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients (2018) (25)
- Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn’s Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab (2015) (25)
- Heart-touching Chilaiditi's syndrome. (2005) (23)
- Esophageal ulceration due to alendronate. (1996) (23)
- Clinically Significant Small Bowel Crohn's Disease Might Only be Detected by Capsule Endoscopy. (2018) (23)
- Intestinal Leiomyosarcoma and Gastroparesis Associated withvon Recklinghausen’s Disease (1999) (19)
- Therapeutic Drug Monitoring and Clinical Outcomes in Immune Mediated Diseases: The Missing Link (2016) (18)
- Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease (2017) (17)
- Preclinical and Undiagnosed Crohn's Disease: The Submerged Iceberg (2016) (17)
- Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease (2020) (16)
- Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale. (2004) (16)
- Management of post-operative Crohn’s disease in 2017: where do we go from here? (2016) (15)
- Colorectal cancer screening in Italy: feasibility and cost-effectiveness in a model area. (1999) (14)
- Tissue Studies in Screened First-degree Relatives Reveal a Distinct Crohn's Disease Phenotype (2014) (14)
- Fibrotic Strictures and Anti-TNF-α Therapy in Crohn’s Disease (2007) (14)
- Microbial dysbiosis in spouses of ulcerative colitis patients: Any clues to disease pathogenesis? (2017) (13)
- Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease? (2021) (13)
- Cavernous transformation of the portal vein associated to multiorgan developmental abnormalities (2004) (12)
- Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease (2019) (12)
- Pre-clinical Crohn's disease: diagnosis, treatment and six year follow-up. (2014) (11)
- Surgery for Crohn’s disease and anti-TNF agents: the changing scenario (2013) (11)
- 749 Infliximab for Prevention of Recurrence of Post-Surgical Crohn's Disease Following Ileocolonic Resection: A Randomized, Placebo-Controlled Study (2015) (10)
- Isolated Bilateral Gastrocnemius Myositis in Crohn Disease Successfully Treated with Adalimumab (2016) (9)
- Noncanonical NF-κB Signaling Upregulation in Inflammatory Bowel Disease Patients is Associated With Loss of Response to Anti-TNF Agents (2021) (8)
- Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune diseases and with dyspepsia. A follow-up study. (1997) (8)
- Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents. (2015) (8)
- Helicobacter pylori, gastric MALT and B-cell clonality. (1996) (8)
- Su1317 Tissue Studies in Screened First Degree Relatives Reveal a Distinct Crohn's Disease Phenotype (2014) (7)
- Translational research and efficacy of biologics in Crohn's disease: a cautionary tale (2014) (7)
- Postoperative recurrence of Crohn's disease: the beginning of the end? (2009) (7)
- Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease (2020) (7)
- Hepatitis C virus infection and gastric lymphoproliferation in patients with Sjögren's syndrome. (1997) (6)
- Tu1155 Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-up and Impact of Infliximab Trough Levels and Antibodies to Infliximab (2013) (6)
- Anti-TNF's for postoperative recurrence in Crohn's disease: the if's and how's. (2010) (6)
- Fibrocytes, Inflammation, and Fibrosis in Crohn’s Disease: Another Piece of the Puzzle (2014) (5)
- The Coming of Age of Inflammatory Bowel Diseases in Asia (2017) (5)
- Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science (2019) (5)
- Helicobacter pylori infection and autoimmune processes: an emerging field of study. (1998) (5)
- Acute severe colitis: infliximab and/or cyclosporine? (2011) (5)
- Knowledge Gaps in the Management of Postoperative Crohn’s Disease: A US National Survey (2017) (4)
- Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet. (2009) (4)
- Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease (2021) (4)
- Infliximab in Crohn's disease: a look at the (not so distant) future. (2008) (4)
- Factors Associated With the Development of Intestinal Strictures or Obstructions in Patients With Crohn's Disease (2006) (4)
- Detailed analysis of total colectomy on health-related quality of life in adult patients with ulcerative colitis (2017) (3)
- Infliximab vs adalimumab for Crohn's disease: perhaps too early to call it a tie. (2014) (3)
- Wireless Capsule Endoscopy for Diagnosis and Management of Post-Operative Recurrence of Crohn’s Disease (2021) (3)
- The role of magnetic resonance imaging in detecting intestinal fibrosis in Crohn's disease. (2012) (3)
- Long-term prevention of postoperative Crohn’s disease recurrence with azathioprine: the wolf in the sheep clothing (2015) (3)
- Hepatocellular sulfobromophthalein uptake at physiologic albumin concentrations: kinetic evidence for a high affinity/low capacity sinusoidal membrane system. (1996) (2)
- Is Ustekinumab Effective in Refractory Crohn’s Disease of the Pouch and Chronic Pouchitis? A Systematic Review (2021) (2)
- The Gut Microbial Profile of Preclinical Crohn's Disease Is Similar to That of Healthy Controls. (2019) (2)
- Noncanonical NF-κB signaling is elevated in inflammatory bowel disease patients and may be associated with therapeutic response (2017) (2)
- Anti-TNFs for prevention of postoperative recurrence of Crohn's disease: a broken record? (2012) (2)
- Mucosal healing and clinical remission in inflammatory bowel diseases: are we missing something here? (2013) (1)
- Fecal Lactoferrin Predicts Primary Nonresponse to Biologic Agents in Inflammatory Bowel Disease (2021) (1)
- Unexplained Symptoms and Hidden Inflammation in Patients With Crohn's Disease. (2019) (1)
- Su1184 - Evaluation of Fecal Lactoferrin and Calprotectin Levels in Healthy Pregnant Women as a Reference for Detecting Inflammatory Bowel Disease (2018) (1)
- 269 Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn's Disease: Partial Benefit by Infliximab - a Pilot Study (2012) (1)
- Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold? (2012) (1)
- Tu1778 – The Gut Microbial Profile of Preclinical Crohn's Disease is Similar to that of Healthy Controls (2019) (1)
- Angiotensin converting enzyme inhibitor induced small bowel angioedema. (2020) (1)
- Low glutamate dehydrogenase levels are associated with colonization in Clostridium difficile PCR-only positive patients with inflammatory bowel disease (2020) (1)
- Novel Diagnostic Tools to Differentiate C. Difficile Disease from Colonization in Patients with Inflammatory Bowel Diseases (2017) (1)
- P088 - Prevention of postsurgical recurrence of Crohn's disease by infliximab: a three years follow-up study (2009) (1)
- Letter: when to withhold anti‐TNF agents prior to abdominal surgery in patients with Crohn's disease—the jury might still be out (2019) (1)
- Diagnostic and Therapeutic Delays in the Management of Postoperative Crohn’s Disease (2019) (0)
- Small Bowel Inflammation in Crohn's Disease and Other Conditions. (2018) (0)
- Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets (2021) (0)
- Longer Time to Crohnʼs Disease Diagnosis Is Associated with Complicated Disease: 632 (2016) (0)
- [Ethical aspects of randomized clinical trials]. (1997) (0)
- Preventing postoperative Crohn's disease with anti-TNFs: Almost there (2012) (0)
- Su1906 A STOOL MARKER-BASED STRATEGY TIMELY AND ACCURATELY PREDICTS LOSS OF RESPONSE AND PRIMARY NON RESPONSE TO BIOLOGICS IN INFLAMMATORY BOWEL DISEASE. (2020) (0)
- Utility of Fecal Markers to Diagnose and Monitor Inflammatory Bowel Diseases (2015) (0)
- USEFULNESS OF CT COLONOGRAPHY IN PATIENTS WITH OCCLUSIVE COLORECTAL CANCER BEFORE METALLIC STENT PLACEMENT: A SINGLE ENTER EXPERIENCE (2015) (0)
- Non-cirrhotic portal hypertension in inflammatory bowel disease. (2020) (0)
- In vitro effects of epinephrine on Na influx into brush border vesicles from the rat kidney. (1987) (0)
- Erratum: Transmembrane TNF-α Density, But Not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease (2017) (0)
- Bringing Top-End Endoscopy to Regional Australia: Hurdles and Benefits (2012) (0)
- With Sjögren's Syndrome Hepatitis C Virus Infection and Gastric Lymphoproliferation in Patients (2012) (0)
- Anti-TNF's for prevention of postoperative recurrence of Crohn's Disease: the state of the art (2012) (0)
- Therapeutic Targets in Inflammatory Bowel Disease: Are We Getting the Point Across? (2018) (0)
- Prevention of postoperative recurrence of Crohn's disease: does the type of surgery matter? (2011) (0)
- Tu1776 – Clostridium Difficile Diagnosis by Toxin Enzyme Immunoassay Versus Molecular Assay Predicts Antibiotic Response in Inflammatory Bowel Disease Patients (2019) (0)
- Chapter 12 Innovative Uses and Emerging Technologies in Endoscopy (2013) (0)
- Correlation of Fecal Lactoferrin with Endoscopic Scores: Impact of Disease Location and Timing of Testing in Inflammatory Bowel Disease Patients (2018) (0)
- Sa1823 - Differentiating C. Difficile Disease from Colonization in Patients with and without Inflammatory Bowel Disease (2018) (0)
- A rare case of hyperproliferative gastropathy. (2015) (0)
- Diagnostic and assessment issues in Crohn’s disease (2013) (0)
- Diagnosis of Preclinical Crohn's Disease: Hurdles, Challenges, and Hopes. (2020) (0)
- Sjögren’s sindrome and appearance of gastric MALT in Helicobacter pilori infection: a comparison with dyspeptic gastritis. (2000) (0)
- Characterization of progression toward lymphoma in Sjogren's syndrome - Use of different molecular analyses in synchronous and metachronous biopsies (1995) (0)
- Anti TNF's for postoperative recurrence of Crohn's disease: the state of the art (2012) (0)
- The Dark Side of Dysphagia: Esophageal Melanocytosis (2019) (0)
- S940 Endoscopic Ultrasound for Diagnosis and Management of Inflammatory Bowel Disease (2021) (0)
- Low-dose biologics to treat inflammatory bowel disease. Ready for prime time? (2019) (0)
- Diagnosis and assessment of Crohn’s disease. (2012) (0)
- The race for mainstream gastrointestinal endoscopy: frontrunners (2012) (0)
- Su1877 Microbiome Profiling of Flora Adhering to the Gut Wall in Crohn's Disease and First Degree Relatives (2016) (0)
- [Prevention of post-surgical recurrence of Crohn's disease. A perspective]. (2009) (0)
- B-cell clonal expansion in gastric biopsies of patients with dyspepsia and autoimmune diseases: Effect of H. pylori eradication (1995) (0)
- Diagnosis and assessment of Crohns disease: the present and the future (2010) (0)
- Innovative Uses and Emerging Technologies in Endoscopy (2013) (0)
- Newfound role for noncanonical NF-κB signaling in Inflammatory Bowel Disease: Gene expression levels serve as a proxy for predicting anti-TNF therapy responsiveness (2019) (0)
- Crohn's disease: half and half. (2020) (0)
- Sa1795 - Clinically Significant small Bowel Crohn's Disease Might only be Detected by Capsule Endoscopy (2018) (0)
- Endoscopic Ultrasound for Diagnosis and Management of Inflammatory Bowel Disease (2021) (0)
- S850 Obesity as Defined by Body Mass Index Is Not a Risk Factor for Post-Operative Recurrence in Crohn's Disease (2022) (0)
- Tu1985 Correlation of Fecal Lactoferrin Concentration and Extent of Colonic Involvement in Patients With Inflammatory Bowel Disease (2016) (0)
- Fecal Lactoferrin and Other Stool Markers during Normal Pregnancy and in Inflammatory Bowel Diseases: A Prospective Study and Review of the Literature (2020) (0)
- Fecal Lactoferrin is Correlated with the Endoscopic Score and is Superior to C-Reactive Protein and White Blood Cell Count in Patients with Inflammatory Bowel Disease (2017) (0)
This paper list is powered by the following services:
Other Resources About Dario Sorrentino
What Schools Are Affiliated With Dario Sorrentino?
Dario Sorrentino is affiliated with the following schools:
